In the five-year agreement, Medtronic will be the exclusive sales agent for Kuros' product in certain U.S. spine geographies.

From new partnerships to acquisitions, here are four key developments from spine and orthopedic medtech companies since Jan. 1.

Kuros Biosciences USA's strategic, exclusive sales agency agreement with Medtronic could boost adoption of its MagnetOs bone ...

Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology.

Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeriesKuros will work collaboratively to sel ...

Medtronic will act as the exclusive sales agent of MagnetOsTM for USA, Inc. in mutually agreed upon sales territories for use in spine surgeries Kuros will work collaboratively to sell, market and ...

Caribou Biosciences, Inc. (CRBU) reported Q3 EPS of ($0.44), $0.04 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $3.3 million versus the consensus ...

Harmony Biosciences had a return on equity of 23.16% and a net margin of 17.98%. The business had revenue of $186.00 million during the quarter, compared to the consensus estimate of $184.07 million.

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Rhythm Biosciences Ltd. has requested a trading halt on its securities as it prepares to make an announcement ...

today announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation diagnostics to consumers and healthcare providers. This acquisition expands OraSure ...

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...